In vivo CAR-T therapy: from molecular design to precision delivery
Engineering CAR-T cells directly in patients' bodies could sidestep expensive manufacturing, making this powerful therapy faster and more accessible.
This review covers the emerging field of in vivo CAR-T cell generation, which aims to bypass the expensive and time-consuming ex vivo manufacturing process. It covers CAR mRNA design, gene delivery advances, and potential clinical applications.
What the study was
- Study design
- Narrative review
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Journal of Nanobiotechnology
Why it surfaced
Timely review of in vivo CAR-T, a rapidly evolving field. No original data but strong conceptual framework.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.